Ligand validation:6BW5

TUM: Tunicamycin

TUM is a Ligand Of Interest in 6BW5 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BW5_TUM_A_501	42%	24%	0.212	0.933	1.71	1.54	13	17	1	0	100%	1
6BW5_TUM_C_501	32%	25%	0.254	0.932	1.7	1.5	13	12	1	0	100%	1
6BW5_TUM_D_501	23%	25%	0.291	0.919	1.69	1.5	14	13	0	0	100%	1
6BW5_TUM_B_501	23%	24%	0.277	0.903	1.71	1.57	13	17	1	0	100%	1
6BW6_TUM_A_501	42%	26%	0.208	0.929	1.67	1.49	13	11	1	0	100%	1
5JNQ_TUM_A_401	46%	53%	0.129	0.902	0.59	1.23	-	8	0	0	79%	0.7895

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.